SML2850

Cediranib

≥98% (HPLC)

• Synonim(y): 4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline, 4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline, 4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline, AZD 2171, AZD2171
• Wzór empiryczny (zapis Hilla): C₂₅H₂₇FN₄O₃
• Numer CAS: 288383-20-0
• Masa cząsteczkowa: 450.51
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD09954115
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• SMILES string: Fc1c2c([nH]c(c2)C)ccc1Oc3ncnc4c3cc(c(c4)OCCCN5CCCC5)OC
• InChI: 1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3
• InChI key: XXJWYDDUDKYVKI-UHFFFAOYSA-N

Opis

Biochem/physiol Actions

Cediranib (AZD2171) is an orally active anticancer agent and a highly potent ATP-competitive receptor tyrosine kinase (RTK) inhibitor against VEGFR (IC₅₀ = 5 nM/Flt-1 (VEGFR1), <1 nM/KDR (VEGFR2), ≤3 nM/Flt-4 (VEGFR3), c-Kit (IC₅₀ = 2 nM), PDGFR1/2 (IC₅₀ = 5/36 nM), and FGFR1 (IC₅₀ = 26 nM). Cediranib exhibits reduced activity against CSF-1R, Src, Abl (IC₅₀ = 110, 130, 260 nM, respectively) and little or no potency toward Flt-3, EGFR, ErbB2 (Her-2/neu), CDK2/4, Aurora A/B, and MEK.

Orally active anticancer agent, highly potent ATP-competitive tyrosine kinase inhibitor against VEGFR1/2/3 (Flt-1/KDR/Flt-4), c-Kit, PDGFR1/2 & FGFR1.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable